From Fragmented IDEs to One Multilingual Platform: Johnson & Johnson’s Positron Story
How Johnson & Johnson unified R and Python development across teams with Positron.
Many large enterprise data science teams struggle with fragmented toolsets for different languages and workflows, which can hinder collaboration, complicate validation, and make reliable scaling difficult, especially in regulated sectors.
Discover how Johnson & Johnson overcame this challenge by moving to a single, enterprise-ready development platform with Positron.
Join us for a customer-led webinar on March 3, 2026, at 12:00 PM ET, featuring Satish Murthy, Senior Manager in Pharma R&D IT at Johnson & Johnson. Satish will discuss their decision-making process, deployment in complex environments, and how Positron enables reproducible, validated workflows in both R and Python without disrupting existing team operations.
Discover how Johnson & Johnson overcame this challenge by moving to a single, enterprise-ready development platform with Positron.
Join us for a customer-led webinar on March 3, 2026, at 12:00 PM ET, featuring Satish Murthy, Senior Manager in Pharma R&D IT at Johnson & Johnson. Satish will discuss their decision-making process, deployment in complex environments, and how Positron enables reproducible, validated workflows in both R and Python without disrupting existing team operations.
Register now
Featured in this webinar
Satish J Murthy
Senior Manager, Pharma R&D IT at Johnson & Johnson
Satish Murthy is a Senior Manager in Pharma R&D IT at Johnson & Johnson. Satish has over 30 years of experience in the pharmaceutical and IT industries. He plays a crucial role in building solutions and High Performance Computing (HPC) platforms focusing on creating validated environments for reproducibility, ensuring that clinical studies and other research activities can be reliably replicated. Satish’s current capabilities include data analytics, reliability engineering, and the implementation of environments to enhance repeatability and reproducibility in pharmaceutical research. His expertise has been instrumental in advancing R&D capabilities, leveraging technology to improve patient outcomes and streamline research processes